Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress
Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD--Improvements Seen in Multiple Cardiac and Skeletal Endpoints ...
The American Journal of Managed Care2d
Inhaled Treprostinil Reduces PH-ILD Hospitalizations, Poster Finds
Two posters presented at the CHEST 2024 annual meeting show that although inhaled treprostinil reduces hospitalizations in ...
MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...
Brown Politcal Review5d
The Student Sentinels
US campuses have played an actively complicit role in the CCP’s efforts to threaten international Chinese students into ...
Daily14d
Sun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024 EADV Congress
Mumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio ...
The Christian Post5dOpinion
Should your newborn baby and kindergartener receive a vaccine for an STD?
The purpose of vaccinating children was originally to stop dangerous diseases that spread easily and quickly in a school room ...
Zacks Small Cap Research on MSN11d
MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS…
MNOV READ THE FULL MNOV RESEARCH REPORT On September 30, 2024, MediciNova, Inc. (NASDAQ:MNOV) announced that MN-166 (ibudilast) will be evaluated in an Expanded Access Protocol (EAP) trial to evaluate ...
Business Wire16d
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...
These 7 new California laws came from 1,000 bills Gov. Gavin Newsom recently signed
In response to rising antisemitism in the state, Newsom signed all four of the California Legislative Jewish Caucus’ priority ...
The Valdosta Daily Times4d
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
The study achieved its primary endpoint demonstrating a statistically significant and clinically meaningful improvement for apitegromab versus placebo in motor function as measured by the gold ...